Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H2 2016" report to their offering.

Avian influenza A (H7N9) is a subtype of influenza viruses. This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia and general malaise. Treatment includes antiviral drugs.

This report provides comprehensive information on the therapeutic development for Influenza A Virus, H7N9 Subtype Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Influenza A Virus, H7N9 Subtype Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Influenza A Virus, H7N9 Subtype Infections Overview
3. Therapeutics Development
4. Pipeline Products for Influenza A Virus, H7N9 Subtype Infections - Overview
5. Pipeline Products for Influenza A Virus, H7N9 Subtype Infections - Comparative Analysis
6. Influenza A Virus, H7N9 Subtype Infections - Therapeutics under Development by Companies
7. Influenza A Virus, H7N9 Subtype Infections - Therapeutics under Investigation by Universities/Institutes
8. Influenza A Virus, H7N9 Subtype Infections - Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Influenza A Virus, H7N9 Subtype Infections - Products under Development by Companies
13. Influenza A Virus, H7N9 Subtype Infections - Products under Investigation by Universities/Institutes
14. Influenza A Virus, H7N9 Subtype Infections - Companies Involved in Therapeutics Development

Companies Mentioned

• EpiVax Inc
• Fab'entech
• Genentech Inc
• GlaxoSmithKline Plc
• Medigen Vaccine Biologics Corp
• NanoViricides Inc
• Visterra Inc
• Vivaldi Biosciences Inc

For more information about this report visit http://www.researchandmarkets.com/research/7pgflh/influenza_a